Completed and ongoing trials examining the role of GLP-1R agonists, especially semaglutide, in the treatment of glaucoma, AMD, Alzheimers, and Parkinsons disease, were searched on the public clinical trial registry clinicaltrials.gov ( NCT04777409, NCT04777396, NCT03811561, NCT01843075, NCT04232969, NCT03659682, NCT02953665, NCT04305002, NCT03439943, NCT04269642, NCT04154072, NCT02673931, NCT02829502, NCT02838589, NCT00418288, NCT00256256, NCT03948347, NCT03287076 , NCT02684578, NCT05035095 )
Fine Lines (Week 6+): Fine line improvement takes longer than dark circle reduction, typically visible after 6-8 weeks of consistent use
Bagnis, A., Izzotti, A., Centofanti, M
You can make simple bars of soap or get crafty by adding fresh herbs and flowers
Patient education : Clear, standardized messaging on medication expectations, side effect management, and lifestyle adjustments